Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Avinger Inc (NQ: AVGR )

3.960 +0.040 (+1.02%)
Streaming Delayed Price Updated: 11:03 AM EDT, Apr 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Avinger Inc

< Previous 1 2 3 Next >
Avinger Reports Fourth Quarter and Full Year 2023 Results
Via ACCESSWIRE
Avinger to Announce Full Year 2023 Results on March 20, 2024
Via ACCESSWIRE
Avinger Announces Strategic Partnership and up to $15 Million Equity Funding Agreement with Zylox-Tonbridge
Via ACCESSWIRE
Avinger Reports Third Quarter 2023 Results
Via ACCESSWIRE
Avinger to Announce Third Quarter 2023 Results on October 26
Via ACCESSWIRE
Avinger Inc. (NASDAQ: AVGR) Leading the Way in Monday Trading Based on Percentage Gain
Via Investor Brand Network
Avinger Raises $5.3 Million via At-The-Market Facility
Via ACCESSWIRE
Avinger Inc. (NASDAQ: AVGR) Near the Top of Equities by Percentage Gain on 9/19
Via Investor Brand Network
Avinger Announces 510(k) Filing of Pantheris LV
Via ACCESSWIRE
Avinger Inc. (NASDAQ: AVGR) Near Top of Volume Charts in Monday Trading
Via Investor Brand Network
Avinger Initiates Full Commercial Launch of Tigereye ST Image-Guided CTO Crossing Device
Via ACCESSWIRE
Avinger Announces Presentations by Key Opinion Leaders at AMP (The Amputation Prevention Symposium) 2023
Via ACCESSWIRE
Avinger Announces Conversion of 12% of CRG Term Debt into Equity
Via ACCESSWIRE
Avinger to Announce Second Quarter 2023 Results on July 27
Via ACCESSWIRE
Avinger Announces Presentations by Key Opinion Leaders at LINC 2023
Via ACCESSWIRE
Avinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual Conference
Via ACCESSWIRE
Avinger Receives 510(k) Clearance for Pantheris LV Image-Guided Atherectomy System
Via ACCESSWIRE
Avinger Announces Successful First Cases with Tigereye ST Image-Guided Chronic Total Occlusion (CTO) Crossing Device
Via ACCESSWIRE
Avinger Reports First Quarter 2023 Results
Via ACCESSWIRE
Avinger to Announce First Quarter 2023 Results on May 10
Via ACCESSWIRE
Leading Data on the Treatment of In-Stent Restenosis with Pantheris Presented at Charing Cross International Symposium
Via ACCESSWIRE
Avinger Receives 510(k) Clearance for Tigereye ST Image-Guided CTO Crossing System
Via ACCESSWIRE
Avinger Reports Fourth Quarter 2022 Results
Via ACCESSWIRE
Avinger to Announce Fourth Quarter 2022 Results on March 15
Via ACCESSWIRE
Avinger Reports Third Quarter 2022 Results
Via ACCESSWIRE
Avinger Announces Issuance of Seven New Patents Expanding Coverage for Its Proprietary Image-Guided Atherectomy Devices
Via ACCESSWIRE
Avinger to Announce Third Quarter 2022 Results on November 9
Via ACCESSWIRE
Avinger to Present at LD Micro Investor Conference
Via ACCESSWIRE
Interim Data from IMAGE-BTK Clinical Trial Presented at AMP 2022
Via ACCESSWIRE
Avinger Reports Second Quarter 2022 Results
Via ACCESSWIRE
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.